Global /South Korea /Industrials /Specialty Business Services /372320

Curocell Inc.

372320

• KRX: 372320 • Delayed

65,000KRW 0.9%

42.41 USD

As of 5 June 2026, Curocell Inc. has a market cap of $298.64M USD, ranking #18622 globally and #610 in South Korea. It ranks #4303 in the Industrials sector, and #452 in the Specialty Business Services industry.

Global Rank

18622

Country Rank

610

Sector Rank

4303

Industry Rank

452

Key Stats

Market Cap

$298.64MUSD

459.06B KRW

Enterprise Value

$664.78MUSD

1.02T KRW

EBITDA (TTM)

-$19.68MUSD

-30.17B KRW

Net Income (TTM)

-$30.12MUSD

-46.31B KRW

PB Ratio

196.3

Company Profile

Country (HQ)

South Korea

Sector

Industrials

Industry

Specialty Business Services

CEO

Kim Gunsoo open_in_new

Founded

2016

Website

curocellbtx.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0.9%	9%	26%	26%	66%	43%	146%	34%	34%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	372320 주식회사 큐로셀 ISIN: KR7372320002 Shares Out.: Shares Outstanding: 15.226M¹ Shares Float: 9.361M² TV: TradingView: KRX: 372320 SA: Stock Analysis: KRX: 372320 YF: Yahoo Finance: 372320.KS GF: Google Finance: KRX: 372320 BA: Barron's: 372320 MS: Morningstar: XKRX: 372320	65,000 KRW	TV: TradingView: KRX: 372320 SA: Stock Analysis: KRX: 372320 YF: Yahoo Finance: 372320.KS GF: Google Finance: KRX: 372320 BA: Barron's: 372320 MS: Morningstar: XKRX: 372320

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Curocell Inc.

Curocell Inc., a cell gene therapy development company, engages in the development and manufacturing of pharmaceuticals. It provides research and development services; and OVercome Immune Suppression (OVIS), a proprietary platform technology designed to get away from exhaustion induced by immune checkpoint receptors. The company is also involved in the development of CD19 CAR-T treatment, blood cancer CAR-T, solid cancer CAR-T, and allogeneic CAR-T. Curocell Inc. was founded in 2016 and is headquartered in Daejeon, South Korea.

Similar Companies

Industry: Specialty Business Services (South Korea)

Name	Market Cap (USD) diff.	PE	Country
HYBE Co., Ltd. KRX: 352820	$7.06B 10.85T KRW 2K%	-	South Korea
Kakao Pay Corp. KRX: 377300	$4.98B 7.65T KRW 2K%	169.0	South Korea
Aimed Bio Inc. KRX: 0009K0	$2.05B 3.15T KRW 587%	627.7	South Korea
S-1 Corp. KRX: 012750	$1.9B 2.93T KRW 538%	16.4	South Korea
DOOSAN TESNA Inc. KRX: 131970	$1.65B 2.54T KRW 453%	69.0	South Korea
AbClon Inc. KRX: 174900	$653.3M 1.0T KRW 119%	-	South Korea

Industry: Specialty Business Services (Global)

Name	Market Cap (USD) diff.	PE	Country
Shopify Inc. NASDAQ: SHOP	$158.14B 53K%	129.8	Canada
Verisure plc STO: VSURE	$133.15B 114.8B EUR 44K%	-	United Kingdom
Cintas Corp. NASDAQ: CTAS	$69.6B 23K%	36.8	United States
RELX PLC LSE: REL	$63.87B 47.6B GBP 21K%	23.9	United Kingdom
PayPal Holdings, Inc. NASDAQ: PYPL	$45.83B 15K%	9.4	United States
T Thomson Reuters Corp. NEO: TRI	$41.8B 56.91B CAD 14K%	-	Canada

chevron_leftBack